News Daily News Frailty Does Not Hinder Dapagliflozin’s HFrEF Impact: DAPA-HF Analysis Caitlin E. Cox May 03, 2022
News Conference News HRS 2022 Registry Shows Watchman FLX Beating First-Gen Device for Early LAAO Outcomes Todd Neale May 02, 2022
News Daily News FDA Approves Mavacamten for Obstructive Hypertrophic Cardiomyopathy Michael O'Riordan April 29, 2022
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for March 2022 Caitlin E. Cox April 01, 2022
News Daily News Postmarketing Studies of CV Devices Still Lacking in the US Caitlin E. Cox March 17, 2022
News Daily News Good Results For TAVI in Bicuspid Valves, but Questions Persist Michael O'Riordan March 08, 2022
News Conference News BIOFLOW V: Orsiro Still Offers Some Benefits at 5 Years Caitlin E. Cox March 02, 2022
News Daily News Female Cardiologists Still Face Pushback as Physician-Researchers Caitlin E. Cox February 28, 2022
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for February 2022 Shelley Wood February 28, 2022
News Daily News FDA Approves Empagliflozin for Treatment of HFpEF Michael O'Riordan February 24, 2022
News Daily News FDA Grants Expanded Indication to CardioMEMS PA Pressure Monitor Shelley Wood February 22, 2022
News Daily News Robert M. Califf Becomes 25th Commissioner of the US FDA L.A. McKeown February 15, 2022
News Opinion Fellow Talk A Trainee’s Perspective on the First Genetically Engineered Pig-to-Human Cardiac Xenotransplantation Corbin E. Goerlich, MD January 13, 2022
News Daily News TCTMD’s Top 10 Most Popular Stories for December 2021 Caitlin E. Cox December 29, 2021